News NeoVax Plus Nivolumab: A Lab Briefing on the Phase 1 TrialBy Hakon EriksenOctober 16, 2026 A technical briefing on NeoVax with nivolumab: the manufacturing pipeline, PD-1 blockade, feasibility endpoints and the limits of a phase 1 result.
